Tenax Therapeutics, Inc. (TENX)
9.71
-0.11
(-1.12%)
USD |
NASDAQ |
Dec 11, 12:23
Tenax Therapeutics Market Cap: 60.63M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 20.24M |
| AIM ImmunoTech, Inc. | 1.146M |
| IGC Pharma, Inc. | 29.91M |
| NovaBay Pharmaceuticals, Inc. | 362.28M |
| Protalix Biotherapeutics, Inc. | 145.16M |
Market Cap Related Metrics
| Price to Book Value | 0.6302 |
| Price | 9.71 |
| Earnings Yield | -11.68% |